David Ohlwein has extensive experience in healthcare regulatory and transactional matters, including: medical device transactions, the federal Anti-kickback statute (AKS), False Claims Act (FCA), HIPAA, Stark Act, and FDA compliance. He previously served as Sr. Legal Director in wide variety of commercial transactions for a $3.5 billion division of a medical device company.

David obtained his J.D. from DePaul University and is admitted to the State Bar of Tennessee.  

To view David’s full firm bio, click here.